返回 
加入收藏
医疗机构药品风险管理认知与现状调研
x
请在关注微信后，向客服人员索取文件
| 篇名： | 医疗机构药品风险管理认知与现状调研 |
| TITLE： | Survey on the perception and current status of drug risk management in medical institutions |
| 摘要： | 目的 了解我国医疗机构药学人员在药品使用过程中对药品风险管理工作的认知和现状，为促进医疗机构药品风险管理体系的完善与发展提供经验和建议。方法采用问卷调查法，面向全国28个省（区、市），采用分层随机抽样，以全国医疗机构的医务工作者、医疗相关药学从业人员群体为研究对象，调查内容包括调查人群信息，医疗机构药品风险管理实施现状，药品风险管理相关概念的认知、含义与流程，医疗机构药品风险管理工作内容及模式；最后，收集完善医疗机构药品风险管理体系建设的建议。采用描述性统计分析对所得数据进行汇总。结果本次调研共回收问卷446份，其中有效问卷420份，无效问卷26份，问卷回收率为100%，有效率为94.17%。51.19%的参研人员对医疗机构药品风险管理认知来源于《药品不良反应报告和监测管理办法》；87.38%的参研人员支持医疗机构药品风险管理的管理范围包括药品使用的全流程。63.33%的参研人员表示自己所在医疗机构设立了医疗机构药品风险管理相关岗位，其中三级甲等及以上医疗机构占比最高（72.17%）。66.43%的参研人员反馈在药品使用全部环节均进行药品风险管理。参研人员针对医疗机构药品风险管理体系发展的建议重点集中在完善制度指导性文件、明确概念内涵、建立信息共享机制等方面。结论目前我国医疗机构药品风险管理总体认知水平较高，其工作正在多环节、多形式地实施开展，但仍需加强相关制度文件、管理规范和体系建设，进一步完善信息共享机制，促进风险管理的社会共治和协作，提高药品管理水平，保障患者用药安全。 |
| ABSTRACT： | OBJECTIVE To know about the perception and current status of drug risk management among pharmacists in Chinese medical institutions， providing insights and recommendations for enhancing the drug risk management system in medical institutions. METHODS A questionnaire survey was conducted across 28 provinces， cities， and autonomous regions； stratified radom sampling was employed to study the population of medical workers and pharmaceutical professionals in medical institutions nationwide. The survey included information on the survey population， the current status of drug risk management implementation in medical institutions， the cognition， definition and process of drug risk management related concepts， and the content and mode of drug risk management work in medical institutions. Finally， suggestions were collected from various medical institutions on the system construction of drug risk management. Descriptive statistical analysis was adopted to summarize the obtained data. RESULTS A total of 446 questionnaires were collected in this survey， including 420 valid questionnaires and 26 invalid questionnaires. The questionnaire collection rate was 100%，and the effective rate was 94.17%. 51.19% of the respondents No.2020YFC2009001）。 based their understanding of drug risk management on Management Measures for Adverse Drug Reaction Reports and Monitoring， while 87.38% recognized the need for drug risk management throughout the drug use process. 63.33% of the participants stated that their medical institutions had dedicated positions related to drug risk management， with the highest proportion （72.17%） was in third-grade class A medical institutions. 66.43% reported implementing risk management across all drug use stages. Suggestions for the development of drug risk management systems in medical institutions by the research participants focused on enhancing guiding documents， clarifying concepts， establishing information-sharing mechanisms. CONCLUSIONS The overall awareness of drug risk management in China’s medical institutions is high， with practices in place across various stages in multiple forms. However， there remains a need to strengthen institutional documents， management regulations， system development， and information-sharing mechanisms to improve collaborative governance， improve drug management levels， and ensure patient safety. |
| 期刊： | 2025年第36卷第01期 |
| 作者： | 孙雪林；邢明青；张子轩；赵文靖；钱东方；梁艳；徐丽；金鹏飞；张亚同 |
| AUTHORS： | SUN Xuelin，XING Mingqing， ZHANG Zixuan，ZHAO Wenjing，QIAN Dongfang，LIANG Yan，XU Li，JIN Pengfei，ZHANG Yatong |
| 关键字： | 药品风险管理；药物警戒；药品安全；医疗机构 |
| KEYWORDS： | drug risk management； pharmacovigilance； drug safety； medical institutions |
| 阅读数： | 3 次 |
| 本月下载数： | 0 次 |
* 注：未经本站明确许可，任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作！
